Clinical Trials Sponsored by Abbott (Peru)

Total 2664 results

Abbott Biologicals

Completed

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2012/2013 Season

Prophylaxis of Influenza

Germany
Abbott Products

Completed

Effect of Choline Fenofibrate (SLV348) on Macular Edema

Diabetic Macular Edema

Bulgaria, Czech Republic, Denmark, Germany, Hungary, Italy, Netherlands, Poland, Spain, United Kingdom
Abbott Products

Completed

14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in Man

Healthy Subjects

Netherlands
Abbott Products

Completed

The CBF Study Evaluating the Effect of Betahistine on the Cerebral Blood Flow (CBF)

Gait or Balance Disorder Problems

Singapore
Abbott Products

Completed

Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than Four Years With Pancreatic Exocrine Insufficiency

Pancreatic Exocrine Insufficiency

Russian Federation
Abbott Products

Terminated

A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy to L-dopa in the Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesia.

Advanced Stage Parkinson's Disease

Germany, Italy, Portugal
Abbott Products

Completed

Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent Miscarriage

Recurrent Miscarriage

Austria, Poland
Abbott Medical Devices
Abbott

Completed

ILUMIEN IV: OPTIMAL PCI

Coronary Artery Disease | Atherosclerosis | Coronary Stenosis | STEMI | NSTEMI - Non-ST Segment Elevation MI | STEMI - ST Elevation Myocardial Infarction

United States, Spain, Australia, United Kingdom, Canada, New Zealand, Denmark, Switzerland, Germany, Netherlands, India, Japan, Italy, Belgium, France, Hong Kong, Portugal, Singapore, Sweden, Taiwan
Abbott Medical Devices
Abbott

Active, not recruiting

MitraClip EXPAND G4 Study

Mitral Regurgitation | Mitral Valve Regurgitation

United States, Canada, Spain, Israel, Germany, Italy, Japan, France, Netherlands, Saudi Arabia
Abbott Medical Devices
Abbott

Completed

The MitraClip® EXPAND Study of the Next Generation of MitraClip® Devices

Mitral Regurgitation | Mitral Valve Regurgitation

Netherlands, United Kingdom, United States, Spain, Israel, Germany, Italy, Switzerland
Abbott

Recruiting

Equivalence Study to Compare Two Strengths of Creon in China (CREON)

Pancreatic Insufficiency

China
Abbott

Completed

Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy Human Adult Subjects

Healthy Subjects | Healthy Participants | Bioequivalence | Human Volunteers

India
Abbott

Completed

A Prospective Observational Program Using Digital Technology Tools to Enhance Patient Adherence to Omacor Therapy (DIAPAsOn)

Hypertriglyceridemia | History of Myocardial Infarction

Russian Federation
Abbott

Completed

Controlled Study to Evaluate the Efficacy and Safety of Racecadotril in Infants, Children and Adolescents With Acute Diarrhea

Diarrhea

Russian Federation
Abbott

Completed

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the Southern Hemisphere 2015 Season

Influenza

Australia
Abbott

Completed

Testosterone Treatment for Hypogonadal Men

Hypogonadism
Abbott

Completed

The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS

HIV Infections | Mycobacterium Avium-intracellular Infection

United States, Puerto Rico
Abbott

Completed

Effect of Digene Total (Buffered Pantoprazole) on 24 Hour Gastric Potential Hydrogen (pH) in Patients From Acid Peptic Disorder After Single and Repeated Dosing.

Acid Peptic Disorder

India
Abbott

Completed

To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subjects With Solid Tumors

Solid Tumor Cancers

United States
Abbott

Completed

A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects With Schizophrenia

Schizophrenia

United States
Abbott

Terminated

Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

Liver Diseases | Digestive System Diseases | Neoplasms | Neoplasms by Histologic Type | Neoplasms by Site | Adenocarcinoma | Carcinoma | Neoplasms, Glandular and Epithelial | Digestive System Neoplasms | Carcinoma, Hepatocellular | Liver Neoplasms | Hepatocellular Carcinoma Non-resectable | Hepatocellular Carcinoma...

United States, Argentina, Australia, Austria, Belgium, Canada, Chile, China, Czech Republic, Denmark, Egypt, France, Germany, Greece, Hong Kong, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, New Zealand, Norway, Puerto... and more
Abbott

Completed

Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Abbott

Completed

Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment With Tarka® Fixed Combination in Patients With Essential Hypertension

Essential Hypertension

Czech Republic
Abbott

Terminated

Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC)

Renal Cell Carcinoma | Metastases

United States
Abbott

Completed

Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis (OPTIMA)

Rheumatoid Arthritis

United States, Argentina, Australia, Austria, Belgium, Canada, Czech Republic, France, Germany, Hungary, Mexico, Netherlands, New Zealand, Norway, Poland, Puerto Rico, Slovakia, South Africa, Spain, Sweden, United Kingdom
Abbott

Completed

Drug Use Investigation of Kaletra

Human Immunodeficiency Virus

Japan
Abbott

Completed

Endometriosis Trial: Study of NBI-56418 in Endometriosis

Endometriosis

United States
Abbott

Completed

Long-term Effectiveness and Safety in Hepatitis-co-infected Patients

Human Immunodeficiency Virus-Infection

Germany
Abbott

Completed

Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis

Ankylosing Spondylitis

China
Abbott

Completed

A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty

Puberty, Precocious

United States, Puerto Rico
Abbott

Completed

Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors

Advanced Solid Tumors

United States
Abbott

Completed

Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease

Crohn's Disease

Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Norway, Portugal, Slovakia, Spain, Sweden, Switzerland, United Kingdom
Abbott

Completed

Evaluation of the Treatment With Klacid®SR in Patients With Lower Respiratory Tract Infection

Bronchitis | Chronic Bronchitis | Community-acquired Pneumonia | Tracheobronchitis | Tracheitis

Slovakia
Abbott

Terminated

A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate Alzheimer's Disease Who Participated in the M06-876 Study

Alzheimer's Disease

United States
Abbott

Completed

Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA)

Arthritis, Juvenile Idiopathic

United States, Belgium, Czech Republic, France, Germany, Italy, Slovakia, Spain
Abbott

Completed

Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease

Crohn's Disease

United States, Belgium, Canada, Czech Republic, France, Netherlands, Poland, United Kingdom
Abbott

Terminated

Creon in HIV Patients With Steatorrhea

Steatorrhea

Romania
Abbott

Completed

A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency

Exocrine Pancreatic Insufficiency, Chronic Pancreatitis

Japan
Abbott

Completed

A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifanib (ABT-869)

Solid Tumors

United States
Abbott

Completed

A Study of Leuprolide to Treat Prostate Cancer

Prostate Cancer

United States
Abbott

Completed

Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis

Ankylosing Spondylitis

Canada
Abbott

Completed

Safety and Tolerability of PG110 in Patients With Knee Osteoarthritis Pain

Osteoarthritis, Knee

Netherlands
Abbott

Completed

Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis (ATLAS)

Ankylosing Spondylitis

United States
Abbott

Completed

Study of Lupron Depot In The Treatment of Central Precocious Puberty

Puberty, Precocious

United States
Abbott

Completed

Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy

Psoriasis

United States, Canada
Abbott

Completed

Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing

Rheumatoid Arthritis

United States, Canada, Puerto Rico, Australia, Germany, United Kingdom
Abbott

Completed

Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis

Ulcerative Colitis

United States, Austria, Belgium, Canada, Czech Republic, Germany, Hungary, Italy, Netherlands, Poland, Puerto Rico, Slovakia, Sweden
Abbott

Completed

Remission in Subjects With Crohn's Disease, 1 Year Phase (CLASSICII)

Crohn's Disease

United States
Abbott

Completed

Remission in Subjects With Crohn's Disease, Open Label Extension (CLASSICII)

Crohn's Disease

United States
Abbott

Completed

Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate

Rheumatoid Arthritis

China

Clinical Trials Sponsored by Abbott (Peru)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations